Hinge Health CFO sells 5,906 shares in plan trade

Hinge Health, Inc. Chief Financial Officer James Budge sold 5,906 shares of Class A Common Stock in open-market transactions.

Rhea-AI Filing Summary

Hinge Health, Inc. Chief Financial Officer James Budge sold 5,906 shares of Class A Common Stock in open-market transactions. The sales occurred on May 11, 2026 at weighted average prices of $55.48 and $54.65 per share under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, he continued to hold 386,293 shares directly, indicating that the trades represent a small portion of his overall stake.

Insights

Insider transactions analyst

CFO’s pre-planned stock sales are modest relative to remaining holdings.

CFO James Budge sold a total of 5,906 shares of Hinge Health, Inc. Class A Common Stock through open-market transactions on May 11, 2026. Sale prices were reported on a weighted-average basis around $55 per share.

The filing states these trades were executed under a Rule 10b5-1 trading plan, indicating they were pre-scheduled rather than opportunistic. After the sales, Budge still directly owned 386,293 shares, so the disposition reflects a relatively small portion of his visible position.

Given the pre-planned nature and the sizeable remaining stake, this activity appears routine from a governance perspective. Subsequent company filings may offer additional context on any further 10b5-1 plan transactions or changes in executive shareholdings.

Insider Trade Summary 10b5-1

Net Seller: 5,906 shares

Net Sell 2 txns

Insider Budge James

Role Chief Financial Officer

Sold 5,906 shs ($324K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	4,706	$54.6506	$257K
Sale	Class A Common Stock	1,200	$55.4775	$67K

Holdings After Transaction: Class A Common Stock — 386,293 shares (Direct)

Footnotes (3)

1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
2. F2. Represents the weighted average sale price. The lowest price at which shares were sold was $54.14 and the highest price at which shares were sold was $55.13. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
3. F3. Represents the weighted average sale price. The lowest price at which shares were sold was $55.18 and the highest price at which shares were sold was $56.05. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Key Figures

Shares sold: 5,906 shares First weighted average sale price: $55.48 per share Second weighted average sale price: $54.65 per share +3 more

6 metrics

Shares sold 5,906 shares Total Class A Common Stock sold on May 11, 2026

First weighted average sale price $55.48 per share Weighted average price for 1,200-share sale

Second weighted average sale price $54.65 per share Weighted average price for 4,706-share sale

Post-transaction holdings 386,293 shares Class A Common Stock directly owned after reported sales

Lower price range $54.14 per share Lowest price reported within weighted-average sale range

Upper price range $56.05 per share Highest price reported within weighted-average sale range

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, open-market sale, Class A Common Stock

4 terms

Rule 10b5-1 trading plan regulatory

"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"Represents the weighted average sale price. The lowest price at which shares were sold was $54.14 and the highest price at which shares were sold was $55.13."

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Class A Common Stock financial

"security_title: Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hinge Health (HNGE) disclose for its CFO?

Hinge Health (HNGE) disclosed that Chief Financial Officer James Budge sold 5,906 shares of Class A Common Stock. The transactions were open-market sales executed on May 11, 2026, under a pre-arranged Rule 10b5-1 trading plan, according to the Form 4 filing.

How many Hinge Health (HNGE) shares does the CFO hold after the Form 4 sales?

After the reported sales, Hinge Health (HNGE) CFO James Budge directly holds 386,293 shares of Class A Common Stock. This post-transaction ownership level shows that the 5,906 shares sold represent a relatively small portion of his overall reported stake.

At what prices did the Hinge Health (HNGE) CFO sell shares on May 11, 2026?

The Hinge Health (HNGE) CFO’s May 11, 2026 sales used weighted average prices of $55.48 and $54.65 per share. Footnotes note sale price ranges between $54.14 and $56.05, with detailed trade breakdowns available on request from the company or regulators.

Was the Hinge Health (HNGE) CFO’s stock sale part of a Rule 10b5-1 plan?

Yes. The Form 4 states the Hinge Health (HNGE) CFO’s reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-schedule trades, which can make the timing less indicative of near-term insider views.

Does the recent Form 4 indicate large insider selling at Hinge Health (HNGE)?

The Form 4 reports that Hinge Health (HNGE) CFO James Budge sold 5,906 shares but still directly owns 386,293 shares. This suggests the sale is modest relative to his remaining stake and, combined with the 10b5-1 plan, appears consistent with routine portfolio management.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 04:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	05/11/2026		S(1)		4,706	D	$54.6506(2)	387,493	D
Class A Common Stock	05/11/2026		S(1)		1,200	D	$55.4775(3)	386,293	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.

2. Represents the weighted average sale price. The lowest price at which shares were sold was $54.14 and the highest price at which shares were sold was $55.13. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

3. Represents the weighted average sale price. The lowest price at which shares were sold was $55.18 and the highest price at which shares were sold was $56.05. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

	/s/ James Budge	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)